2026's IPO Boom Meets Its First Real Stress Test: 911 Million SpaceX Shares and a Late-July Pipeline

The IPO market has not had a year like this in a long time. Through July, U.S. operating companies have raised $142.5 billion across 87 public offerings — within a whisker of 2021’s full-year record of $141 billion^[1]. But the number that defines this market sits beneath the headline: two deals — SpaceX and SK Hynix — alone accounted for over $100 billion^[2]. Strip those out, and the remaining 85 IPOs raised roughly $27 billion in the second quarter, which is still triple the first quarter’s $9 billion but tells you how concentrated the capital has been.

Now the market faces a test it has not faced since the cycle turned: the first major lockup expiration of the era’s defining IPO, arriving exactly as the late-July pipeline shifts from mega-deals to mid-cap consumer and crypto-adjacent names. What happens in the first two weeks of August will tell us a great deal about whether the issuance window stays wide or narrows.

SpaceX: From Record Listing to Below IPO Price in Six Weeks

SpaceX (SPCX) priced at $135 on June 11 and began trading the next day, briefly touching an intraday high of $225.64 in mid-June. As of the July 24 close, the stock sat at $115.07, with extended-hours pushing it to $113.37 — down roughly 49% from peak and 14.8% below the IPO price^[3][4].

The selloff has multiple drivers, but the dominant one is supply overhang. Short interest is elevated: Ortex Technologies estimated about 360 million shares out on loan as of mid-July, roughly 56% of the free float^[4]. Short sellers’ unrealized gains had reached $15.5 billion, and Ortex co-founder Peter Hillerberg noted that “there is no sign of short sellers taking profits… if anything they are leaning in harder”^[4].

The real reckoning comes on August 6. As many as 911.5 million restricted shares become eligible for sale after SpaceX’s Q2 earnings report (scheduled after market close on August 4)^[4]. That is 1.41 times the current public float of 646 million shares. Being eligible does not guarantee selling — but the ratio alone tells you the float could more than double overnight if even a fraction of holders decide to take chips off the table.

What would have to be true for this to go well? SpaceX’s Q2 results would need to show Starlink revenue scaling meaningfully, and the Starship program would need to demonstrate consistent progress. Flight 13 on July 25 deployed 20 V3 satellites and showed improved reentry, but five booster engines failed to relight — an advance, not a breakthrough^[4]. The earnings call will be the first detailed financial look at a company that listed with a roughly $2 trillion market cap and now trades at roughly half its peak value.

I’d put the probability of an orderly August at maybe 55/45 — and the 45 is not a small number. The short interest that has weighed on the stock could fuel a squeeze if earnings surprise positively, but the sheer volume of potentially unlockable shares creates a structural selling pressure that no amount of operational progress fully offsets in the short term.

SK Hynix: The Foreign Listing Template

The second pillar of 2026’s IPO surge was SK Hynix (SKHY), the South Korean memory chipmaker whose ADRs raised $26.5 billion on Nasdaq — the largest U.S. listing by a foreign company ever^[2]. The ADRs opened at $170, 14% above the $149 offer price, and closed the first day at $168.01, up 13%^[5].

But SK Hynix’s ADRs also slipped after the debut — dropping roughly 10% within days as the initial enthusiasm faded^[5]. The pattern echoes what SpaceX has experienced: strong first-day pop, followed by a gradual repricing as the market digests valuation and supply dynamics. For 2026’s pipeline, the lesson is that even well-received mega-IPOs face a post-debut gravity that lockup expirations can intensify.

The Nasdaq IPO Pulse — a leading indicator of IPO activity based on cyclical drivers — remains near its 18-month high and in an upturn, suggesting continued issuance into late 2026^[2]. But the Pulse measures pipeline momentum, not post-listing performance. The divergence between strong filing activity and soft aftermarket trading is exactly the kind of pattern that, historically, has preceded a narrowing of the issuance window.

The Late-July Pipeline: A Different Class of Deal

The week ahead tests whether investor appetite extends beyond mega-cap tech listings. Three deals are set to close out July:

Jersey Mike’s is the largest of the three and the most telling. The sandwich chain filed S-1 paperwork on July 2 and launched its roadshow July 20, targeting 43.5 million shares at $21–$25, with 68% of the offering coming from existing stockholders rather than new company shares^[6][7]. The deal would value the company at up to $7.94 billion — almost exactly what Blackstone paid for its stake less than two years ago^[6].

The high secondary component matters. When the majority of an IPO’s proceeds go to selling stockholders rather than the company, it tells you the insiders are taking money off the table at a price they find attractive. That is not inherently negative — Blackstone-backed exits are a normal part of the private-equity-to-public-market pipeline — but it does mean the deal is partly a liquidity event for existing holders rather than fresh capital for growth. In a market where the largest recent IPO has already broken below its issue price, the willingness of investors to absorb a $1 billion secondary-heavy consumer deal is a real signal of demand depth.

Reformation is smaller and simpler — a $225 million raise targeting up to $1 billion in valuation, with $507.1 million in FY2025 net revenue (up 15.7% year-over-year)^[8]. It is a direct-to-consumer apparel story at a time when DTC multiples have been compressed across the sector.

Ionic Digital is the wildcard — a direct listing (not a traditional IPO) for a Celsius-backed digital infrastructure company pivoting from Bitcoin mining toward AI and high-performance computing^[9]. Direct listings carry no new capital raise and no traditional underwriter price support, so price discovery will be entirely market-driven. At a potential ~$2 billion valuation, it tests whether crypto-adjacent infrastructure names can command AI-style multiples.

The Secondary Market: Follow-Ons Keep Flowing

While the IPO pipeline commands attention, the follow-on offering market has been quietly active. REGENXBIO (RGNX) announced a $100 million underwritten secondary on July 16^[10]. Codexis (CDXS) priced a public offering of 16.7 million shares on July 23^[10]. AEON Biopharma (AEON) priced an upsized $13.75 million offering with milestone warrants on July 13^[10]. DarioHealth (DRIO) priced a $23.5 million registered direct offering on July 22^[10].

The pattern is clear: smaller-cap biotech and health-tech companies are tapping the follow-on market steadily, suggesting institutional demand for new issuance remains functional at the small-cap end even as the mega-IPO aftermarket softens. These are not marquee deals, but they are the plumbing of the market — and so far, the plumbing is working.

Buybacks: The Counterweight

On the other side of the ledger, repurchase announcements continue. Flagstar Bank (FLG) authorized a $250 million buyback program on July 24, citing strong capital position^[11]. Equinor commenced the third tranche of its 2026 buyback program, targeting up to $1.125 billion^[11]. RELX announced a £150 million non-discretionary buyback program following the completion of a £100 million program^[11]. A.P. Moller-Maersk continued its $1 billion 12-month buyback program^[11].

Buybacks withdraw supply from the market just as IPOs and secondaries add it. The net effect on aggregate liquidity depends on the scale of each side, but the continued pace of repurchase authorizations — particularly from financials and energy — provides a counterweight to the issuance-heavy environment.

What to Watch Next

Three events in the first two weeks of August will set the tone for the rest of 2026’s IPO market:

1. August 4 — SpaceX Q2 earnings (after close): The first detailed financial look at the company since listing. Starlink revenue trajectory, Starship development costs, and any commentary on capital structure will be parsed for signals about whether the $2 trillion market cap franchise can grow into its valuation.

2. August 6 — SpaceX lockup expiration: Up to 911.5 million restricted shares become eligible for sale^[4]. This is the single largest liquidity event of the 2026 IPO cycle. The market’s ability to absorb even partial selling will be read as a verdict on demand depth — not just for SpaceX, but for the broader class of recent listings.

3. Late July — JMKE, REF, and IOND pricing and first-day performance: Jersey Mike’s pricing (expected during the week of July 28), Reformation’s expected July 29 pricing^[8], and Ionic Digital’s July 28 direct listing^[9] will show whether investor appetite extends to mid-cap consumer and digital-infrastructure names. First-day pops above the range would signal the window is still wide; cuts or breaks would suggest it is narrowing.

The filing pipeline offers a buffer: 153 IPOs have been filed year-to-date, up 10.1% from last year^[1]. That is a substantial backlog that could come to market if conditions remain supportive. But the gap between filing and pricing is where market appetite gets tested — and August will test it harder than any month since the cycle began.

FN2 Research provides financial research and education, not personalized investment advice. All figures are sourced from publicly available data at the time of writing and are subject to change.